Alginates Market Regional Analysis:
APAC Market Insights
Asia Pacific is predicted to have the largest alginates market share registering over 36% by 2035. In September 2023, WHO stated that despite being highly preventable, cardiovascular disease (CVD) remains the leading cause of mortality in Asia-Pacific, accounting for 3.9 million deaths in the WHO South-East Asia Region every year. With developing healthcare infrastructure and rising cases of chronic diseases, there has been a greater emphasis on advanced wound management and drug delivery systems in countries such as India and China. These factors have boosted the region's need for alginates significantly.
Japan market is driven by the rising demand for processed meat and seafood products. Alginate casings, derived from seaweed, offer advantages such as better moisture retention, improved texture, and enhanced shelf life for food products. Additionally, the increasing emphasis on food safety and sustainability has led to a preference for plant-based, biodegradable casings. In November 2020, KIMICA Corporation completed the expansion of its powder blending and packaging facilities for alginate production at its factory in Chiba, Japan, increasing its annual production capacity to over 2000MT to meet the rising demand.
North American Market Insights
North America industry is estimated to register a significant share by 2035. Rising demand in the food, pharmaceutical, and personal care industries due to its thickening, stabilizing, and gelling properties, is significantly driving the market growth. The region also benefits from well-established production facilities and advanced R&D efforts focused on innovative applications. Increased consumer preference for natural and clean-label ingredients has also fueled market growth.
The France alginates market is primarily influenced by the food and beverage industry, where it is widely used in dairy products, dressings, and bakery items. Rising demand for plant-based and functional foods has further boosted alginate usage. Advancements in controlled drug delivery systems also contribute to the market’s expansion in the country. In February 2023, Algaia announced the expansion of the Algaia R&D center in Saint Lô with the help of funding from Saint Lô Agglo. The expansion comprises new laboratories with state-of-the-art equipment and additional offices to support R&D activities for the growth of Algaia.